Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content type

Project (21)

Country

Austria (3)
Belgium (11)
Burkina Faso (1)
Czech Republic (2)
Denmark (6)
Finland (5)
France (13)
Germany (19)
Ireland (3)
Italy (13)
Luxembourg (3)
Netherlands (17)
Norway (1)
Poland (1)
Senegal (1)
Slovenia (2)
Spain (8)
Sweden (9)
Switzerland (8)
United Kingdom (21)
United States (5)

Advanced search

Search projects and results

Results 1 - 10 of 21
Results/page:
12 3 > 
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
ID: 115902
Start date: 2016-04-01, End date: 2021-03-31
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at...
Programme: H2020-EU.3.1.7.13.
Record Number: 209453
Last updated on: 2017-05-23
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
ID: 115881
Start date: 2016-07-20, End date: 2020-03-31
The stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, inform clinical trial design, and the establishment of regulatory paths for the adoption of novel strategies for diabetes prevention and...
Programme: H2020-EU.3.1.7.6.
Record Number: 209450
Last updated on: 2017-03-27
Patient Preferences in benefit risk assessments during the drug life cycle
ID: 115966
Start date: 2016-11-16, End date: 2021-09-30
The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i.e. in the early stages of identifying medical needs, in clinical testing, to guide decisions on reimbursement and to make decisions on...
Programme: H2020-EU.3.1.7.
Record Number: 209460
Last updated on: 2017-03-27
Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN)
ID: 115850
Start date: 2015-03-10, End date: 2017-11-30
This topic response (Topic 2: Manufacturing Capability) forms part of an integrated proposal to address the urgent unmet needs of accelerating the development of an Ebola vaccine. To help facilitate this main goal additional activities will be performed; the generation of...
Programme: H2020-EU.3.1.7.13.
Record Number: 209444
Last updated on: 2017-03-27
Biomarker Enterprise to Attack DKD
[PROJECT] BEAt-DKD - Biomarker Enterprise to Attack DKD
ID: 115974
Start date: 2017-01-06, End date: 2021-08-31
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached epidemic dimensions in recent years. Unfortunately, there are no effective means to prevent or cure DKD. Apart from...
Programme: H2020-EU.3.1.7.
Record Number: 209459
Last updated on: 2017-03-27
Ultra-Fast Molecular Filovirus Diagnostics
ID: 115844
Start date: 2015-02-01, End date: 2017-08-31
There is an urgent need for fast and accurate diagnostic tests in future Ebola outbreak situations. The rapid diagnosis of Ebola Virus Disease (EVD) during early and late stage of infection is a decisive step for risk assessment and for guidance to physicians to take the...
Programme: H2020-EU.3.1.7.13.
Record Number: 209449
Last updated on: 2017-03-27
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II
ID: 115861
Start date: 2014-12-01, End date: 2017-11-30
The main objective therefore of EBOVAC 2 is to provide extensive and robust data on the safety, immunogenicity and efficacy of the Ad26.ZEBOV and MVA-BN-Filo vaccine.This will be done by:1. Carrying out translational studies to link vaccine elicited immune responses in humans...
Programme: H2020-EU.3.1.7.13.
Record Number: 209445
Last updated on: 2017-03-27
Ebola Virus: Modern Approaches for developing  bedside Rapid Diagnostics
ID: 115843
Start date: 2015-02-01, End date: 2018-01-31
The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now a serious public health crisis of...
Programme: H2020-EU.3.1.7.13.
Record Number: 209451
Last updated on: 2017-03-27
Amyloid imaging to Prevent Alzheimer’s Disease
ID: 115952
Start date: 2016-12-08, End date: 2021-09-30
Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD). Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary...
Programme: H2020-EU.3.1.7.
Record Number: 209458
Last updated on: 2017-03-27
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.
ID: 115847
Start date: 2014-12-01, End date: 2017-11-30
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners...
Programme: H2020-EU.3.1.7.13.
Record Number: 209447
Last updated on: 2017-03-27
12 3 > 
List retrieved on: 2017-06-26